RT Journal
A1 Shreibati J, Baker LC, Hlatky MA
T1 EValuation for coronary artery disease and medicare spending—reply
JF JAMA
JO JAMA
YR 2012
FD March 7
VO 307
IS 9
SP 911
OP 912
DO 10.1001/jama.307.9.912-a
UL http://dx.doi.org/10.1001/jama.307.9.912-a
AB 
We would contend, however, that the ultimate measure of the value of CCTA will be its effect on clinical outcomes, not its sensitivity or specificity. Comparative studies with long-term follow-up are needed to compare CCTA with stress testing in the evaluation of patients with suspected CAD.